Three insights:
1. The company aims to use the net proceeds for working capital and other corporate purposes.
2. All shares in the offering are to be sold by SeaSpine.
3. SeaSpine plans to give the underwriters a 30-day option to buy up to an additional 15 percent of the shares of common stock offered in the public offering.
More articles on devices:
Orthopedic clinic faces renewed lawsuit over 2016 cyberattack
Orthopedics unit restructures workforce to boost efficiency — 5 details
Optim Orthopedics performs four free joint replacements
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
